AKAM tops Q4 estimates as Guardicore and API security fuel 7% revenue growth, while 2026 outlook signals steady margin and earnings expansion.

AKAM tops Q4 estimates as Guardicore and API security fuel 7% revenue growth, while 2026 outlook signals steady margin and earnings expansion.

ED beats Q4 earnings and revenue estimates as electric, gas and steam sales rise, while issuing 2026 EPS guidance of $6.00-$6.20.

PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.

PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.

KRYS beats Q4 estimates as Vyjuvek sales jump 17%. It secures 660+ U.S. reimbursements and advances the gene therapy pipeline into 2026.

KRYS beats Q4 estimates as Vyjuvek sales jump 17%. It secures 660+ U.S. reimbursements and advances the gene therapy pipeline into 2026.

MCY tops Q4 estimates as premiums rise, investment income jumps and catastrophe losses fall, driving a 32% profit surge, while revenues are up 7% and...

MCY tops Q4 estimates as premiums rise, investment income jumps and catastrophe losses fall, driving a 32% profit surge, while revenues are up 7% and...

INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.